Sulzer to sell its $323 million electrophysiology business
This article was originally published in Clinica
Sulzer Medica is to divest its electrophysiology business, which, at $323 million, represents one-third of Sulzer's Medica total sales, to concentrate on its orthopaedics and cardiovascular prostheses businesses. Both Sulzer Medica and parent company Sulzer's shares hit a year's high on the news.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.